对于的治疗方法是艾弗梅克丁.

Same author

RIFM Fragrance ingredient safety assessment, 2-nonen-1-ol, CAS registry number 22104-79-6.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2018

Same author

A national methodology to quantify the diet of grazing dairy cows.

Journal of dairy science·2018

Same author

RIFM fragrance ingredient safety assessment, bis(hydroxymethyl)tricyclo[5.2.1.02,6]decane, CAS Registry Number 26160-83-8.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2018

Same author

RIFM fragrance ingredient safety assessment, 1,3-dimethylbut-3-enyl isobutyrate, CAS Registry Number 80118-06-5.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2018

Same author

RIFM fragrance ingredient safety assessment, 4'-methylacetophenone, CAS Registry Number 122-00-9.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2018

Same author

RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate, CAS registry number 67634-20-2.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2018

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

对于的治疗方法是艾弗梅克丁.

相关概念视频

RIFM Fragrance ingredient safety assessment, 2-nonen-1-ol, CAS registry number 22104-79-6.

A national methodology to quantify the diet of grazing dairy cows.

RIFM fragrance ingredient safety assessment, bis(hydroxymethyl)tricyclo[5.2.1.02,6]decane, CAS Registry Number 26160-83-8.

RIFM fragrance ingredient safety assessment, 1,3-dimethylbut-3-enyl isobutyrate, CAS Registry Number 80118-06-5.

RIFM fragrance ingredient safety assessment, 4'-methylacetophenone, CAS Registry Number 122-00-9.

RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate, CAS registry number 67634-20-2.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

对于的治疗方法是艾弗梅克丁.

相关概念视频

相关文章

RIFM Fragrance ingredient safety assessment, 2-nonen-1-ol, CAS registry number 22104-79-6.

A national methodology to quantify the diet of grazing dairy cows.

RIFM fragrance ingredient safety assessment, bis(hydroxymethyl)tricyclo[5.2.1.02,6]decane, CAS Registry Number 26160-83-8.

RIFM fragrance ingredient safety assessment, 1,3-dimethylbut-3-enyl isobutyrate, CAS Registry Number 80118-06-5.

RIFM fragrance ingredient safety assessment, 4'-methylacetophenone, CAS Registry Number 122-00-9.

RIFM fragrance ingredient safety assessment, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate, CAS registry number 67634-20-2.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.